Edition:
United Kingdom

Ankur Banerjee

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

14 Feb 2020

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

14 Feb 2020

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

13 Feb 2020

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

Indian generic drugmakers may see supply shortages from China if coronavirus drags on

13 Feb 2020

Feb 13 Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

GSK profit falls short as cheap competition hits older drugs

05 Feb 2020

GlaxoSmithKline missed fourth-quarter earnings forecasts on Wednesday as cheap competition to the British drugmaker's respiratory medicines offset strong growth in sales of its shingles vaccine.

GSK raises profit forecast after shingles vaccine sales boost

30 Oct 2019

GlaxoSmithKline on Wednesday raised its annual profit forecast for the second time this year as sales of its shingles vaccine beat expectations and older medicines, including HIV treatments, continued to sell well.

AstraZeneca raises sales forecast after surge in cancer drugs

24 Oct 2019

AstraZeneca lifted its annual drug sales forecast for the second time this year after a surge in revenue from newer cancer treatments, but warned that changing policies in China, its second-biggest market, would crimp growth next year.

For would-be elite soldiers, healthier diets may pay off

27 Sep 2019

(Reuters Health) - A study of soldiers trying to get into an elite army unit adds to evidence linking healthy diets to better physical performance.

Customers can make fast-food combo meals healthier

26 Aug 2019

(Reuters Health) - Combination meals in U.S. fast food and fast casual restaurants have lots of calories, saturated fat, sugar and sodium, but customers can make the meals healthier by substituting drinks and toppings, researchers say.

Pfizer to spinoff, merge off-patent drugs unit with Mylan

29 Jul 2019

Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar. | Video

World News